BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2991048)

  • 21. Insulin secretion by a transplantable rat islet cell tumour.
    Sopwith AM; Hutton JC; Naber SP; Chick WL; Hales CN
    Diabetologia; 1981 Sep; 21(3):224-9. PubMed ID: 6117493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of suppression of insulin secretion by exercise in patients with insulinoma.
    Järhult J; Ericsson M; Holst J; Ingemansson S
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):391-4. PubMed ID: 6274547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homologous desensitization of the insulinotropic glucagon-like peptide-I (7-37) receptor on insulinoma (HIT-T15) cells.
    Fehmann HC; Habener JF
    Endocrinology; 1991 Jun; 128(6):2880-8. PubMed ID: 1645253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of immunoreactive-insulin release from a rat cell line (RINm5F).
    Praz GA; Halban PA; Wollheim CB; Blondel B; Strauss AJ; Renold AE
    Biochem J; 1983 Feb; 210(2):345-52. PubMed ID: 6134520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutrient induced insulin release from an insulinoma derived B-cell line.
    Lambert DG; Atkins TW
    Acta Diabetol Lat; 1987; 24(4):299-304. PubMed ID: 2830753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
    Hansen LH; Abrahamsen N; Hager J; Jelinek L; Kindsvogel W; Froguel P; Nishimura E
    Diabetes; 1996 Jun; 45(6):725-30. PubMed ID: 8635644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of in vitro insulin release from a transplantable Syrian hamster insulinoma.
    Shapiro S; Eto S; Fleischer N; Baum SG
    Endocrinology; 1975 Aug; 97(2):442-7. PubMed ID: 169125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose dependence of insulinotropic actions of pituitary adenylate cyclase-activating polypeptide in insulin-secreting INS-1 cells.
    Rosengren A; Filipsson K; Jing XJ; Reimer MK; Renström E
    Pflugers Arch; 2002 Jul; 444(4):556-67. PubMed ID: 12136276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagonlike peptide-1(7-36)amide suppresses glucagon secretion and decreases cyclic AMP concentration in cultured In-R1-G9 cells.
    Matsumura T; Itoh H; Watanabe N; Oda Y; Tanaka M; Namba M; Kono N; Matsuyama T; Komatsu R; Matsuzawa Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):503-8. PubMed ID: 1378730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of calcium channels of a glucose-responsive rat insulinoma.
    Hoenig M; Russo LL; Ferguson DC
    Am J Physiol; 1989 Apr; 256(4 Pt 1):E488-93. PubMed ID: 2539735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells.
    Göke R; Conlon JM
    J Endocrinol; 1988 Mar; 116(3):357-62. PubMed ID: 2832504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual action of protein kinase C activation in the regulation of insulin release by muscarinic agonist from rat insulinoma cell line (RINr).
    Yamatani T; Chiba T; Kadowaki S; Hishikawa R; Yamaguchi A; Inui T; Fujita T; Kawazu S
    Endocrinology; 1988 Jun; 122(6):2826-32. PubMed ID: 2836174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino-terminal parathyroid hormone-related protein: specific binding and cytosolic calcium responses in rat insulinoma cells.
    Gaich G; Orloff JJ; Atillasoy EJ; Burtis WJ; Ganz MB; Stewart AF
    Endocrinology; 1993 Mar; 132(3):1402-9. PubMed ID: 8382601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of binding sites for oxyntomodulin on a somatostatin-secreting cell line (RIN T3).
    Gros L; Demirpence E; Jarrousse C; Kervran A; Bataille D
    Endocrinology; 1992 Mar; 130(3):1263-70. PubMed ID: 1371446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of insulin/insulin-like growth factor-1 receptors on the insulinoma cell, RIN-m5F.
    Colman PG; Harrison LC
    Biochem Biophys Res Commun; 1984 Oct; 124(2):657-62. PubMed ID: 6093809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytosolic insulin-degrading activity in islet-derived tumor cell lines and in normal rat islets.
    Bhathena SJ; Timmers KI; Oie HK; Voyles NR; Recant L
    Diabetes; 1985 Feb; 34(2):121-8. PubMed ID: 2981750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C; Egan JM; Roth J
    Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin, glucagon, and somatostatin receptors on cultured cells and clones from rat islet cell tumor.
    Bhathena SJ; Oie HK; Gazdar AF; Voyles NR; Wilkins SD; Recant L
    Diabetes; 1982 Jun; 31(6 Pt 1):521-31. PubMed ID: 6295859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of islet somatostatin secretion and gene expression: selective effects of adenosine 3',5'-monophosphate and phorbol esters in normal islets of Langerhans and in a somatostatin-producing rat islet clonal cell line 1027 B2.
    Patel YC; Papachristou DN; Zingg HH; Farkas EM
    Endocrinology; 1991 Apr; 128(4):1754-62. PubMed ID: 1672273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.